Author's posts
Commercial Scale Production Of Rare Cannabinoids Is Finally Possible
Synthetic biology company Demetrix has discovered it is more economical and socially responsible to make cannabinoids through fermentation. Now the company is scaling up with a new partnership.
Printable DNA “Ink” Just Took A Big Step Forward
What if we could make DNA into an ink and put it inside a printer? This is the type of technology that Molecular Assemblies is working. The goal is to make DNA ink that can be used for genomics printers to create nucleic acid-based vaccines and other t…
New Genome Test Shows A Child’s Risk Of Disease — Before They’re Born
Orchid’s Couple Report is a saliva-based genetic test that couples can take at home to determine if their future child would have a higher risk of certain genetic diseases.
A New Approach To CRISPR – Scribe Therapeutics Designs Novel CRISPR Molecules
Scribe Therapeutics is creating an advanced platform for CRISPR-based genetic medicine through developing novel CRISPR molecules.
The Latest Quantified Self Trend: Whole-Body MRI
Prenuvo is part of the quantified self movement that focuses on monitoring and collecting personal data to improve your health. Here’s what I discovered.
Meet The UK’s First Synthetic Biology Unicorn
Pure and synthetic DNA from Touchlight in the United Kingdom could be the type of disruptive technology that manufacturers need to scale.
Pharmaceutical Manufacturing Just Got An Automation Boost From IoT
Pharmaceutical manufacturing in the U. S., they face stringent requirements from the FDA to meet cleanroom regulations. But the EDGMaker series could make cleanroom compliance easier and save companies millions in FDA fines.
America, Your Diet Is Killing You: Why The Glucose Crisis Will Be Worse Than The Opioid Crisis
The Levels app shows me that even supposedly healthy options—like the organic juice drink I used to grab at the gym—send my blood glucose sky-high.
Synthetic Biology Startup Acquires AI Platform To Disrupt The Drug Industry
Synthetic biology company AbSci’s recent acquisition of the artificial intelligence platform, Denovium, could help get novel therapeutics to patients more quickly
Could CRISPR Eradicate Acne?
Acne treatment could be entering a new phase using CRISPR and synthetic biology innovation.
